Welcome by co-hosts:

• Dr Morena Makhoana, CEO - Biovac
• Mr Rajinder Suri, CEO - DCVMN

Opening Remarks: Mr Adriansjah Azhari, Board Chair - DCVMN International

• Dr Tedros Adhanom Ghebreyesus (Video Message), Director General - WHO
• Mr David Marlow*, Chief Executive Officer (Ad Int) - Gavi, TheVaccine Alliance
• Dr Richard Hatchett (Virtual), Chief Executive Officer - CEPI
• Dr Jarbas Barbosa da Silva Jr. (Video Message), Director - PAHO
• Dr Nicaise Ndembi, Senior Advisor to the DG of the Africa CDC
• Prof Padmashree Gehl Sampath (Virtual), iCEO - African Pharmaceutical Technology Foundation & Senior Advisor to the President Pharmaceuticals and Health - African Development Bank Group
• Chief guest address by H.E. Mr Paul Shipokosa Mashatile,Honourable Deputy President of the Republic of South Africa

Vote of thanks: Mr Tiago Rocca, Deputy Board Chair - DCVMN

Chair - Dr Nicaise Ndembi, Senior Advisor to the DG of the Africa CDC

• Mr Roy Himawan, Director General of Pharmaceutical andMedical Devices Resilience - Ministry of Health, Indonesia
• Ms Jessica Milman, Global Head Center for Vaccine Innovationand Access - PATH
• Ms Nafisa Jiwani, Managing Director, Health Initiatives - DFC
• Mr Patrick Tippoo, Executive Director - AVMI & Chief Scienceand Innovation Officer - Biovac & Advisor - DCVMN Board
• Dr Stavros Nicolaou, Group Senior Executive Strategic TradeDevelopment - Aspen
• Ms Farrah Losper, Commercial Director - Biovac

Q&A

Chair - Dr David Robinson, Deputy Director, Chemistry,Manufacturing and Control, Clinical Vaccine Development, Global Health - BMGF

Co-Chair - Ms Tania Cernuschi, Unit Head, Immunization Agenda,Policy and Strategy - WHO

• Prof William Ampofo, Chief Executive Officer - NationalVaccine Institute & Chair - AVMI Board
• Dr Matthew Downham, Director Manufacturing & Supply ChainNetworks - CEPI
• Dr Dominic Hein, Director, Market Shaping - Gavi, The Vaccine Alliance
• Dr Michael Karl Schunk, Senior Industry Specialist - IFC
• Prof Petro Terblanche, Chief Executive Officer - AfrigenBiologics
• Dr Rakeshnie Ramoutar-Prieschl, Acting Deputy Director,General Technology and Innovation - Department of Science & Innovation, South Africa
• Dr Rajeshwari Adhiseshan, Senior Program Officer Chemistry,Manufacturing & Controls, Vaccine Development - BMGF
• Mr Brandon Ball, Head of Government Affairs - Temptime (asubsidiary to Zebra Technologies)
  • Vaccine Vial Monitors: Over 10 billion delivered; ready tosupport regional vaccine production

Q&A

Chair - Dr Yukiko Nakatani, Assistant Director-General, Access to Medicines and Health Products - WHO

• Dr Deusdedit Mubangizi, Unit Head Prequalification Unit (PQT) Regulation & Prequalification Department – WHO
• Mr Rajeev Singh Raghuvanshi (Virtual), Drug Controller General (India)- CDSCO
• Dr Boitumelo Semete-Makokotlela (Virtual), CEO - SAHPRA
• Dr Fabricio Carneiro de Oliveira, Head of Biological Products and Advanced Therapy Medicinal Products, ANVISA - MoH Brazil
• Dr Adam Hacker, Director & Head of Global Regulatory Affairs -CEPI
• Dr Carmen Rodriguez Hernandez, Team Lead, Vaccines PQ Regulation and Prequalification Department - WHO
• Dra Togi Junice Hutadjulu (Virtual), Acting Deputy for Drug,Narcotics, Psychotropic, Precursor, and Addictive Substance Supervision - NRA Indonesia
• Dr Lindiwe Makubalo, Assistant Regional Director - WHO Regional Office

Q&A  

Chair: Ms Tania Cernuschi, Unit Head, Immunization Agenda, Policy and Strategy -WHO

• Mr Greg Widmyer, Director and Senior Advisor Global Development - BMGF
• Dr Andrew Owain Jones, Principal Advisor and Chief, Vaccine Centre - UNICEF-SD
• Prof Glenda Gray, President - South African Medical Research Council (SAMRC)
• Dr Leonie de Munter, Senior Epidemiologist - P95
• Dr Appolinaire Lamah, Department of Public Health & Migration, International Organization for Migration, Guinea
• Prof Dr Nico Vandaele, Professor of Operations Research and Operations Management, Access-To-Medicines Research Centre - Ku Leuven, Belgium

Q&A

Chair: Mr Mukesh Chawla, Chief Advisor Health Security - World Bank

• Ms Zeynep Kantur Ozenci, Global Manager and Global Head of Health - International Finance Corporation (IFC), World Bank Group
• Dr Pierre A. Morgon, Executive Vice President, Portfolio Strategy and Supranational Affairs, Managing Director-CanSinoBIO Europe
• Mr Santiago Cornejo, Executive Manager - PAHO
• Mr Hilton Lazarus, Business Unit Head - IDC
• Mr Gerard Cunningham, Operating Partner - Adjuvant Capital

Q&A

Chair - Dr Sunil Gairola - Executive Director - SII & Board Member - DCVMN International

• Mr. Vikrant Hedau, Director of Bio Business Division - Tofflon India
• Mr Youssef Gaabouri, Associate Director, Head of Sales Middle East & Africa - Merck
  • Successful conditions for vaccine local manufacturing inAfrica

Q&A 

Chair - Dr Jicui Dong, Unit Head Local Production and AssistanceUnit Regulation & PQ, Access to Medicines and Health Products Division - WHO

• Dr Simone Blayer, Global Head, Chemistry, Manufacturing, Control and Nonclinical Toxicology - PATH
• Dr Chiluba Mwila, Talent Development - PAVM
• Dr Frauke Uekermann, Director, Vaccine Markets - CHAI
• Ms Emma Wheatley, Director, Access and Private Partnerships -CEPI
• Dr Ali Alloueche, VP, Global Head Business Development, Alliance Management & External R&D - Hilleman Laboratories
• Ms Yalda Momeni, Senior Specialist Future Supplier Based Strategy Market Shaping - Gavi, The Vaccine Alliance
• Mr Murat Hakan Öztürk, Supply Chain Advisor for PAHO Revolving Fund - PAHO
• Ms Iin Susanti, Production and Supply Chain Director - BioFarma, Indonesia

Q&A

Chair - Ms Julia Kuhn, Officer, Strategy Planning and Management, Vaccine Development - BMGF

• Ms Amanda Zehnder, Senior OD and Change Management Advisor - PATH
• Mr John Balchunas (Virtual), Workforce Director - NIIMBL
• Dr Chiluba Mwila, Talent Development - PAVM
• Ms Barbara Ngouyombo, Partnerships Associate Director - Institut Pasteur de Dakar
• Ms Julianne Puckett (Virtual), Principal Consultant, Digital Product Strategy - Nexight Group
• Launch of DCVMN/NIIMBL Workforce Directory

Q&A

at the Gold Restaurant, Cape Town

Chair - Emeritus Prof Anna-Lise Williamson, Senior ResearchScholar, Division of Medical Virology, Department of Pathology - University of Cape Town - Academic Innovations to Accelerate Technological Transfers

• Prof Maria Elena Bottazzi (Video Message), Co-director ofTexas Children’s Center for Vaccine Development - Baylor College of Medicine
• Ms Jennifer Brant (Virtual), Executive Director - Innovation Insights
  • Policymaking to support innovation, tech transfer, and local production
• Dr Simon Agwale – CEO - Innovative Biotech (Nigeria) & Innovative Biotech (USA) & Board Member & Chair of Vaccine Technical working group - AVMI
  • Bringing International Vaccine Development and Manufacturing Expertise to Nigeria through Partnerships and Tech Transfer
• Dr Peter Dull, Deputy Director, Integrated Clinical Vaccine Development, Global Health Division - BMGF
  • Combination vaccines for global health: Why their importance continues to grow
• Dr Laura B. Martin, Director Vaccine Programs, Global Health - US Pharmacopeia
• Dr Glaudina Loots, Director Health and Innovation - Departmentof Science and Innovation in South Africa
• Dr Daniel Cardoso, Vice President - BiOZEEN
  • Biozeen approach for vaccine production infrastructure development in Africa
• Mr Mathias Garny, CEO - Univercells Technologies
  • A low footprint vaccine manufacturing platform for in-country, for-country production
• Mr Jesal Doshi, Deputy CEO - B Medical Systems
  • Saving Lives: Empowering Reliable Vaccine Deliveries Until the Last Mile

Q&A

Chair: Ms Mahima Datla, Managing Director-Biological E

• Mr Sai D Prasad, Executive Director - Bharat Biotech & Advisor - DCVMN Board
• Mr Abdul Muktadir, Chairman & Managing Director - Incepta
• Dr Mauricio Zuma Medeiros, CEO - Bio-Manguinhos/Fiocruz
• Dr Hun Kim, Global R&D President - SK Biosciences
• Dr Esper Georges Kallás, Director - Instituto Butantan
• Dr Amadou Alpha Sall, CEO - Institut Pasteur de Dakar
• Dr Morena Makhoana, CEO - Biovac
• Mr Soleh Ayubi, Deputy CEO - PT BioFarma
• Mr Fernando Lobos, Director - Sinergium Biotech

Q&A

Chair: Mr Dominic Hein, Director, Market Shaping - Gavi, The Vaccine Alliance

• Mr Venkatraman Sivaramakrishnan, Board Member – DCVMN
• Dr Georgios Stathopoulos (Virtual), Technical Officer - WHO
• Ms Shirley Quesada, Unit Chief Revolving Fund Procurement -PAHO
• Mr Joshua Chu, Executive Vice President of Vaccines, Non-Communicable Diseases and
• Disability - CHAI
• Dr Ankur Mutreja (Virtual), Global South Partnerships Lead -CEPI
• Mr Ken Osei, Principal Investment Officer - IFC
• Dr Sushant Sahastrabuddhe, Acting Deputy Director General of CARE (Clinical-Assessment-Regulatory-Evaluation) Unit - IVI

Q&A 

Chair - Mr Sai D Prasad, Executive Director - Bharat Biotech & Advisor - DCVMN Board

• Dr Umesh Shaligram, Executive Director - Serum Institute of India
• Dr Kapil Maithal, President Vaccines & Diagnostics - Zydus Life Sciences
• Dr Erman Tritama, Senior Manager in nOPV production - PT BioPharma
• Dr Andrew Zilong Wong, CEO - Shanghai Wotai Biotech, aWalvax subsidiary
• Dr Raches Ella, Chief Development Officer - Bharat Biotech
• Mr Alfred Luitjens, Global Technical Sales Director - Batavia Biosciences
• Dr Markus Kuehberger, Senior Director Business Line Chemical & Pharma, BU Separators - GEA Group
  • Innovative, hiqh quality vaccine production with GEAtechnology
• Dr Rahul Joshi, Business Head, Cell Biology & Immunology - HiMedia Labs
• Mr Andrea Zambon, Vice President, Corporate Business Development - Stevanato Group
  • How SG can support local vaccines Manufacturing in Africa
• Dr Kerry R. Love, Co-founder & CEO/President - Sunflower Therapeutics
  • Democratizing Biomanufacturing of Recombinant Proteins
• Mr Alex Wang, Managing Director (MEA) - Truking Technology
  • TRUKING turnkey solutions for Vaccines and Bio products
• Prof Emanuele Montomoli, Chief Scientific Officer - VisMederi
  • Assays for vaccines evaluation and correlates of protection
• Mr Olli Rundgren, CEO - Psyon Games

Q&A

Chair - Ms Rachel Park, Board Member - DCVMN

• Dr. Beverley Anne Cowper, Medical Officer - Biovac
• Ms Fernanda Castro Boulos, Chief Medical Officer - Instituto Butantan
• Prof Eliane Matos dos Santos, Epidemiologist physician - Bio-Manguinhos/Fiocruz
• Ms Iin Susanti, Production & Supply Chain Director - Bio Farma, Indonesia
• Ms Meng Li, Director of International Cooperation - Sinopharm, CNBG

Q&A 

Close of 24th DCVMN AGM